Last updated on June 2020

The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression


Brief description of study

The Safety and Efficacy of Psilocybin in Participants with Treatment Resistant Depression

Detailed Study Description

The Safety and Efficacy of Psilocybin in Participants with Treatment Resistant Depression - a dose-ranging study

Clinical Study Identifier: NCT03775200

Find a site near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.